
### [NCIT:C9294](http://purl.obolibrary.org/obo/NCIT_C9294)
**Label:** Histiocytic and Dendritic Cell Neoplasm

**Subclasses:** [NCIT:C134177](http://purl.obolibrary.org/obo/NCIT_C134177) (Refractory Langerhans Cell Histiocytosis), [NCIT:C3107](http://purl.obolibrary.org/obo/NCIT_C3107) (Langerhans Cell Histiocytosis), [NCIT:C81772](http://purl.obolibrary.org/obo/NCIT_C81772) (Disseminated Juvenile Xanthogranuloma), [NCIT:C134172](http://purl.obolibrary.org/obo/NCIT_C134172) (Recurrent Histiocytic and Dendritic Cell Neoplasm), [NCIT:C114483](http://purl.obolibrary.org/obo/NCIT_C114483) (Childhood Langerhans Cell Histiocytosis), [NCIT:C3160](http://purl.obolibrary.org/obo/NCIT_C3160) (Letterer-Siwe Disease), [NCIT:C134175](http://purl.obolibrary.org/obo/NCIT_C134175) (Recurrent Langerhans Cell Histiocytosis), [NCIT:C81758](http://purl.obolibrary.org/obo/NCIT_C81758) (Fibroblastic Reticular Cell Tumor), [NCIT:C123395](http://purl.obolibrary.org/obo/NCIT_C123395) (Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement), [NCIT:C27260](http://purl.obolibrary.org/obo/NCIT_C27260) (Dendritic Cell Tumor, Not Otherwise Specified), [NCIT:C114929](http://purl.obolibrary.org/obo/NCIT_C114929) (Adult Langerhans Cell Histiocytosis), [NCIT:C123396](http://purl.obolibrary.org/obo/NCIT_C123396) (Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement), [NCIT:C3016](http://purl.obolibrary.org/obo/NCIT_C3016) (Eosinophilic Granuloma), [NCIT:C81767](http://purl.obolibrary.org/obo/NCIT_C81767) (Indeterminate Dendritic Cell Tumor), [NCIT:C134168](http://purl.obolibrary.org/obo/NCIT_C134168) (Refractory Histiocytic and Dendritic Cell Neoplasm), [NCIT:C53972](http://purl.obolibrary.org/obo/NCIT_C53972) (Erdheim-Chester Disease), [NCIT:C136489](http://purl.obolibrary.org/obo/NCIT_C136489) (Refractory Erdheim-Chester Disease), [NCIT:C6921](http://purl.obolibrary.org/obo/NCIT_C6921) (Langerhans Cell Sarcoma), [NCIT:C6920](http://purl.obolibrary.org/obo/NCIT_C6920) (Hand-Schuller-Christian Disease), [NCIT:C129808](http://purl.obolibrary.org/obo/NCIT_C129808) (Central Nervous System Erdheim-Chester Disease), [NCIT:C129807](http://purl.obolibrary.org/obo/NCIT_C129807) (Central Nervous System Histiocytic Sarcoma), [NCIT:C27349](http://purl.obolibrary.org/obo/NCIT_C27349) (Histiocytic Sarcoma), [NCIT:C129806](http://purl.obolibrary.org/obo/NCIT_C129806) (Central Nervous System Langerhans Cell Histiocytosis), [NCIT:C92944](http://purl.obolibrary.org/obo/NCIT_C92944) (Central Nervous System Histiocytic and Dendritic Cell Neoplasm), [NCIT:C9282](http://purl.obolibrary.org/obo/NCIT_C9282) (Interdigitating Dendritic Cell Sarcoma), [NCIT:C9281](http://purl.obolibrary.org/obo/NCIT_C9281) (Follicular Dendritic Cell Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 56.86%
- [NCIT:C9229](http://purl.obolibrary.org/obo/NCIT_C9229) (Systemic Disease) 51.41%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) 51.41%
- [NCIT:C60643](http://purl.obolibrary.org/obo/NCIT_C60643) (Adulthood Lesion) 50.70%
- [NCIT:C48616](http://purl.obolibrary.org/obo/NCIT_C48616) (Unifocal Lesion) 50.70%
- [NCIT:C43261](http://purl.obolibrary.org/obo/NCIT_C43261) (Multiple Destructive Bone Lesions) 50.70%
- [NCIT:C43259](http://purl.obolibrary.org/obo/NCIT_C43259) (Multifocal Multisystem Disease) 50.70%
- [NCIT:C43258](http://purl.obolibrary.org/obo/NCIT_C43258) (Multifocal Unisystem Disease) 50.70%
- [NCIT:C41051](http://purl.obolibrary.org/obo/NCIT_C41051) (Solitary Mass) 50.70%
- [NCIT:C39808](http://purl.obolibrary.org/obo/NCIT_C39808) (Asymptomatic Mass) 50.70%
- [NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease) 50.70%
- [NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion) 50.70%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 50.70%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 50.70%
- [NCIT:C41040](http://purl.obolibrary.org/obo/NCIT_C41040) (Lytic Bone Lesion) and (not ([NCIT:C35371](http://purl.obolibrary.org/obo/NCIT_C35371) (Lytic Metastatic Bone Lesion))) 50.70%


